Ciprofloxacin: initial evaluation in immunocompromised patients.
Newland
A C
AC
Department of Haematology, London Hospital, England.
Wood
M E
ME
D000970:Antineoplastic Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D016026:Bone Marrow Transplantation; D002939:Ciprofloxacin / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology
D000970:Antineoplastic Agents; D002939:Ciprofloxacin